FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Comments Sought on Radioactive Drug Regs Info

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on the information collection in regulations on the use of radioactive drugs for basic...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Align Technology, Anchor Products Co., Energy Technology, and Gunnell.

Inspire Medical to Begin Pivotal Apnea Trial

[ Price : $8.95]

FDA gives Inspire Medical Systems approval to begin a pivotal clinical trial called STAR (Stimulation Therapy for Apnea Reduction)...

Review Process Strains FDA-Industry Relations

[ Price : $8.95]

PricewaterhouseCoopers says relations between industry and FDA over regulatory review processes are becoming strained.

FDA Grants 'Orphan' Status for Radiation Exposure Drug

[ Price : $8.95]

FDA grants Cleveland BioLabs an orphan drug designation for CBLB502, a drug under development for treating radiation exposure.

CDER Affirms Ranbaxy Generic Aricept Exclusivity

[ Price : $8.95]

CDER says that Ranbaxy is entitled to 180-day marketing exclusivity for generic Aricept.

Concerns Raised About ABSSSI Draft Guidance

[ Price : $8.95]

PhRMA raises concerns with two aspects of an FDA draft guidance on developing drugs to treat acute bacterial skin and skin structu...

Align Technology Warned on MDR Violations

[ Price : $8.95]

FDAs San Francisco District Office warns Align Technology of Medical Device Reporting violations associated with its Invisalign Sy...

Class 1 Recall for B. Braun addEASE Binary Connectors

[ Price : $8.95]

FDA posts a 6/28 urgent Class 1 recall of B. Brauns fluid transfer addEASE binary connector because stopper fragments may enter a ...

Panel to Discuss Electroconvulsive Therapy Devices

[ Price : $8.95]

Federal Register Notice: FDAs Neurological Devices Panel will meet 1/27-28/11 to discuss reclassifying electroconvulsive therapy d...